VoiceMed
Vocal biomarker factory for a more proactive healthcare system worldwide
- Stage Prototype Ready
- Industry Healthcare Services
- Location Luxembourg
- Currency EUR
- Founded November 2020
- Employees 7
- Incorporation Type LLC
- Website voicemed.io
Company Summary
VoiceMed is revolutionizing respiratory health with vocal biomarkers. Our vision is to create a world where anyone can monitor their health proactively using just their smartphone. Operating on a B2B subscription model, we integrate our smartphone-based lung function test into health insurers’ and providers’ apps. With an 80% accuracy validated in clinical trials and scalable pricing (€0.10–€1/test), we offer a cost-effective, accessible solution
Team
-
Chief Excecutive OfficerWith an MSc in Business Administration and experience in global consulting (Accenture), she specializes in digital health innovation. Recognized in Forbes' "30 Under 30," Arianna is also a professor at Università Cattolica and a TEDx speaker, passionate about democratizing health technology and empowering proactive healthcare.
-
Fulvio CordellaCTOFulvio is an expert in vocal biomarkers, with a background in biomedical engineering. He developed AI models for Parkinson's diagnosis, achieving 98% accuracy. Combining his artistic and scientific skills, Fulvio leads the development of VoiceMed’s algorithms, driving innovation in respiratory health diagnostics.
-
Ayana MartinsCSOAyana holds a PhD in computational biology and has over 9 years of experience in life sciences and technology. A certified EU medical device regulatory expert, she ensures VoiceMed’s platform meets clinical and regulatory standards. Ayana bridges the gap between AI technology and healthcare, ensuring compliance and clinical relevance in the development of new medical technologies.
Advisors
Previous Investors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.